Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Cipla
Baxter
Deloitte
US Department of Justice
Mallinckrodt
Boehringer Ingelheim
Julphar
Daiichi Sankyo
Colorcon

Generated: October 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019422

« Back to Dashboard
NDA 019422 describes EXIDINE, which is a drug marketed by Xttrium and is included in four NDAs. It is available from twenty-five suppliers. Additional details are available on the EXIDINE profile page.

The generic ingredient in EXIDINE is chlorhexidine gluconate. There are fifty-seven drug master file entries for this compound. Sixty suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.

Summary for NDA: 019422

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Dental and Oral Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 019422

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EXIDINE
chlorhexidine gluconate
SOLUTION;TOPICAL 019422 NDA Xttirum Laboratories, Inc. 0116-1021 0116-1021-01 15142 mL in 1 JUG (0116-1021-01)
EXIDINE
chlorhexidine gluconate
SOLUTION;TOPICAL 019422 NDA Xttirum Laboratories, Inc. 0116-1021 0116-1021-04 118 mL in 1 BOTTLE, PLASTIC (0116-1021-04)

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:SOLUTION;TOPICALStrength2%
Approval Date:Dec 17, 1985TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Johnson and Johnson
Deloitte
Cerilliant
QuintilesIMS
Federal Trade Commission
AstraZeneca
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot